1. Podcasts
  2. Squawk Pod
  3. 5 Things to Know Before the Opening Bell 11/10/2025
Squawk Pod

10 Nov 2025 · 3m

Episode artwork

5 Things to Know Before the Opening Bell 11/10/2025

In short

In this episode of Squawk Pod, co-host Andrew Ross Sorkin discusses five critical business and news updates that investors should be aware of before the market opens. The episode encapsulates significant corporate moves, regulatory updates, and industry shifts affecting various sectors.

Written by AI. May contain mistakes.

A man walking through an airport, asking his phone a question

Ask about this episode

Get the gist, explore an idea or ask about something said.

Claude

On Squawk Pod, what are the key points of this episode?

Searching your listening

Transcript

Automatic transcript. May contain errors.

0:01I'm Andrew Ross Sorkin, co-host of Squawk Box along with Joe Kernan and Becky Quick and this is five Five things to know before today's opening bell. Pfizer winning a bidding war for the obesity drug developer Metzera. Now, Metzera is accepting a swinged offer from Pfizer late Friday, citing U.S. antitrust risks from another bid by Novo Nordisk. Meantime, shares of Diageo, they're higher. The company has appointed the former CEO of U.K. grocer giant Tesco as its new CEO. Dave Lewis is going to be taking over at the start of 2026. And UPS and FedEx grounding their combined fleet now of more than 50 McDonnell Douglas and MD-11 cargo planes.

0:40That follows that crash of a UPS MD-11 in Kentucky last week that killed at least 14 people. And Visa and MasterCard are closing in on a settlement with merchants over credit card interchange fees after two decades of legal wrangling. That's according to a Wall Street Journal report. And the leader and head of news at the BBC resigning amid criticism over the way the news organization edited a speech by President Trump on January 6th, 2021, before protesters stormed the U.S. Capitol. Critics said the way the speech was edited for a BBC documentary last year was misleading and removed context. We talked about it at length, that's Sarah.

1:21So it's$10 billion. Remember, Pfizer was at$7.3, and it was done, and they had regulatory approval and everything. And then Novo Nordisk, Ozempic, they wanted it so badly, they came in at 9, and people weren't sure whether they could even do it. And then Pfizer actually matched the sweetened bid from Novo Nordisk. Actually, a little bit above, look, it could be worth as much as$10 billion. It just shows you Pfizer needed to get in, you know, after, you know, betting the ranch on COVID type stuff and the stocks in the 20s. And this is going to be people say it's going to be one hundred and twenty five billion dollar industry market.

1:59Look at that. MetSera shares down by almost 15 percent. And Novo expected that bid to continue. Pfizer shares are up to them. Yeah. You know, at least not down. A lot of money, but yeah. We're going to be back later today with an all new Squawk Pod, our daily podcast featuring the best of Squawk Box. Check it out wherever you get your podcasts and listen anytime.

From the publisher

Pfizer has won a bidding war for obesity drug developer Metsera, Diageo has hired Tesco’s Dave Lewis as its new CEO, FedEx and UPS will ground their flights of MD-11 planes after one of those planes crashed at the UPS aviation hub in Kentucky, Visa and Mastercard are nearing a settlement on interchange fees for merchants, affecting the way shoppers use rewards programs, and BBC’s head of news has resigned over edits a Panorama documentary made to a speech by President Trump.

 

Squawk Box is hosted by Joe Kernen, Becky Quick and Andrew Ross Sorkin.  Follow Squawk Pod for the best moments, interviews and analysis from our TV show in an audio-first format.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

More from Squawk Pod

All episodes